Correlation Between Zura Bio and Ocugen
Can any of the company-specific risk be diversified away by investing in both Zura Bio and Ocugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Ocugen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and Ocugen Inc, you can compare the effects of market volatilities on Zura Bio and Ocugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Ocugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Ocugen.
Diversification Opportunities for Zura Bio and Ocugen
Very poor diversification
The 3 months correlation between Zura and Ocugen is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Ocugen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocugen Inc and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Ocugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocugen Inc has no effect on the direction of Zura Bio i.e., Zura Bio and Ocugen go up and down completely randomly.
Pair Corralation between Zura Bio and Ocugen
Given the investment horizon of 90 days Zura Bio Limited is expected to under-perform the Ocugen. In addition to that, Zura Bio is 1.29 times more volatile than Ocugen Inc. It trades about -0.14 of its total potential returns per unit of risk. Ocugen Inc is currently generating about -0.02 per unit of volatility. If you would invest 81.00 in Ocugen Inc on December 28, 2024 and sell it today you would lose (9.00) from holding Ocugen Inc or give up 11.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Zura Bio Limited vs. Ocugen Inc
Performance |
Timeline |
Zura Bio Limited |
Ocugen Inc |
Zura Bio and Ocugen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zura Bio and Ocugen
The main advantage of trading using opposite Zura Bio and Ocugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Ocugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocugen will offset losses from the drop in Ocugen's long position.Zura Bio vs. Day One Biopharmaceuticals | Zura Bio vs. Mirum Pharmaceuticals | Zura Bio vs. Rocket Pharmaceuticals | Zura Bio vs. Avidity Biosciences |
Ocugen vs. Vaxart Inc | Ocugen vs. Novavax | Ocugen vs. Rain Enhancement Technologies | Ocugen vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |